These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 3527706)
21. Dexamethasone suppression test as an aid for selection of specific antidepressant drugs in patients with endogenous depression. Rihmer Z; Arató M; György S; Révai K; Demeter E Pharmacopsychiatry; 1985 Sep; 18(5):306-8. PubMed ID: 4048265 [TBL] [Abstract][Full Text] [Related]
22. Maprotiline versus imipramine and placebo in neurotic depression. van der Velde CD J Clin Psychiatry; 1981 Apr; 42(4):138-41. PubMed ID: 7009592 [TBL] [Abstract][Full Text] [Related]
23. A controlled double-blind clinical trial between maprotiline and amitriptyline in depressive illness. Okasha A; Sadek A J Egypt Med Assoc; 1976; 59(5-6):557-62. PubMed ID: 801741 [No Abstract] [Full Text] [Related]
24. Relationship between blood concentrations and clinical effects of a new antidepressant "maprotiline". Watanabe S; Yokoyama S; Kubo S; Iwai H; Kuyama C Folia Psychiatr Neurol Jpn; 1980; 34(2):147-56. PubMed ID: 7007180 [TBL] [Abstract][Full Text] [Related]
25. A comparison of maprotiline (Ludiomil) and amitriptyline (1). Dell AJ J Int Med Res; 1977; 5 Suppl 4():22-4. PubMed ID: 338398 [TBL] [Abstract][Full Text] [Related]
26. Therapeutic superiority of maprotiline versus doxepin in geriatric depression. Gwirtsman HE; Ahles S; Halaris A; DeMet E; Hill MA J Clin Psychiatry; 1983 Dec; 44(12):449-53. PubMed ID: 6361005 [TBL] [Abstract][Full Text] [Related]
27. [Comparative clinical study of the association of chlordiazepoxide-amitriptyline and maprotiline in patients suffering from depression with anxiety components]. Tsaras G; Ambrus J Rev Med Suisse Romande; 1981 Jun; 101(6):483-6. PubMed ID: 7029696 [No Abstract] [Full Text] [Related]
28. Amitriptyline and nortriptyline response profiles in unipolar depressed patients. Lehmann LS; Bowden CL; Redmond FC; Stanton BC Psychopharmacology (Berl); 1982; 77(2):193-7. PubMed ID: 6812139 [TBL] [Abstract][Full Text] [Related]
29. Maprotiline in affective illness. Plasma concentration and clinical response. Norman TR; Burrows GD; Maguire KP; McIntyre IM; Scoggins BA J Affect Disord; 1983 May; 5(2):147-54. PubMed ID: 6222094 [TBL] [Abstract][Full Text] [Related]
30. Maprotiline-a double-blind study of a new tetracyclic antidepressant in severe depression. Molnar G Can Psychiatr Assoc J; 1977 Feb; 22(1):19-23. PubMed ID: 322834 [TBL] [Abstract][Full Text] [Related]
31. Maprotiline and amitriptyline in the treatment of depressive illness. A double-blind comparison. Levin A S Afr Med J; 1974 Jan; 48(2):47-9. PubMed ID: 4595136 [No Abstract] [Full Text] [Related]
32. A double-blind comparison of bupropion and amitriptyline in depressed inpatients. Davidson J; Miller R; Van Wyck Fleet J; Strickland R; Manberg P; Allen S; Parrott R J Clin Psychiatry; 1983 May; 44(5 Pt 2):115-7. PubMed ID: 6406438 [TBL] [Abstract][Full Text] [Related]
33. Comparison of the efficacy of sustained-release amitriptyline with maprotiline in the treatment of depressive illness. Sims AC Curr Med Res Opin; 1980; 6(8):534-9. PubMed ID: 7389384 [TBL] [Abstract][Full Text] [Related]
34. Time course of improvement under antidepressant treatment: a survival-analytical approach. Stassen HH; Delini-Stula A; Angst J Eur Neuropsychopharmacol; 1993 Jun; 3(2):127-35. PubMed ID: 8364348 [TBL] [Abstract][Full Text] [Related]
35. Plasma tryptophan and tyrosine ratios to competing amino acids in relation to antidepressant response to citalopram and maprotiline. A preliminary study. Møller SE; de Beurs P; Timmerman L; Tan BK; Leijnse-Ybema HJ; Stuart MH; Petersen HE Psychopharmacology (Berl); 1986; 88(1):96-100. PubMed ID: 3080781 [TBL] [Abstract][Full Text] [Related]
36. Effect of antidepressant treatment on platelet 5-HT content and relation to therapeutic outcome in unipolar depressive patients. Mück-Seler D; Jakovljević M; Deanović Z J Affect Disord; 1991 Nov; 23(3):157-64. PubMed ID: 1774431 [TBL] [Abstract][Full Text] [Related]
37. Treatment strategy in depression. I. Non-tricyclic and selective reuptake inhibitors in resistant depression: a double-blind partial crossover study on the effects of oxaprotiline and fluvoxamine. Nolen WA; van de Putte JJ; Dijken WA; Kamp JS; Blansjaar BA; Kramer HJ; Haffmans J Acta Psychiatr Scand; 1988 Dec; 78(6):668-75. PubMed ID: 3146890 [TBL] [Abstract][Full Text] [Related]
38. Amoxapine and amitriptyline: serum levels and clinical response in patients with primary unipolar depression. Click MA; Zisook S J Clin Psychiatry; 1982 Sep; 43(9):369-71. PubMed ID: 6749828 [TBL] [Abstract][Full Text] [Related]
39. A comparison of maprotiline (Ludiomil) and amitriptyline (2). Mindham BA J Int Med Res; 1977; 5 Suppl 4():25-33. PubMed ID: 338399 [TBL] [Abstract][Full Text] [Related]
40. [Psychometric findings in treatment using the selective MAO-A inhibitors moclobemide and maprotiline]. Classen W Psychiatr Prax; 1989 Aug; 16 Suppl 1():41-3. PubMed ID: 2587675 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]